Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Esophageal Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
- Status
- RECRUITING
- Phase
- N/A
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
- Status
- RECRUITING
- Phase
- NA
A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC
- Status
- UNKNOWN
- Phase
- PHASE2
Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC
- Status
- UNKNOWN
- Phase
- NA
A Multicenter Cancer Biospecimen Collection Study
- Status
- RECRUITING
- Phase
- N/A
Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE)
- Status
- UNKNOWN
- Phase
- N/A
Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)
- Status
- UNKNOWN
- Phase
- PHASE2
Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0 ESCC
- Status
- RECRUITING
- Phase
- PHASE3
Registry Platform Gastric/Esophageal Cancer (SAPHIR)
- Status
- RECRUITING
- Phase
- N/A
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2